the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
Recruiting · NCT06622603 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 4 | 2026-04-29 | NCT06622603 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si | South Korea | 9 |